Satellos Bioscience Inc. Common Stock Net Asset Quality Index
Satellos Bioscience Inc. Common Stock net asset quality index. Satellos Bioscience Inc. Common Stock (MSLE) has a Net Asset Quality Index of 91.1% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $65.69 Million minus total liabilities of $5.85 Million yields net assets of $59.84 Million. A higher index indicates a stronger, lower-leverage balance sheet. See what is Satellos Bioscience Inc. Common Stock's book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Satellos Bioscience Inc. Common Stock (2007–2025)
Net asset quality index of Satellos Bioscience Inc. Common Stock from 2007 to 2025. This chart shows how Satellos Bioscience Inc. Common Stock's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of June 2026, the index stands at 91.1%, representing net assets of $59.84 Million against total assets of $65.69 Million USD. Check MSLE PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Satellos Bioscience Inc. Common Stock Net Asset Quality Index by Year (2007–2025)
Satellos Bioscience Inc. Common Stock net asset quality index by year from 2007 to 2025. The table below presents the year-by-year Net Asset Quality Index for Satellos Bioscience Inc. Common Stock from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see MSLE market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.1% | $27.78 Million | $31.89 Million | $4.11 Million | ▼ -5.8 pp |
| 2024 | 92.9% | $47.28 Million | $50.88 Million | $3.59 Million | ▲ +1.1 pp |
| 2023 | 91.8% | $40.67 Million | $44.30 Million | $3.62 Million | ▲ +37.5 pp |
| 2022 | 54.3% | $3.34 Million | $6.14 Million | $2.80 Million | ▼ -28.9 pp |
| 2021 | 83.3% | $8.22 Million | $9.87 Million | $1.65 Million | ▲ +99.6 pp |
| 2020 | -16.3% | $-184.25K | $1.13 Million | $1.32 Million | ▼ -61.3 pp |
| 2019 | 45.0% | $678.67K | $1.51 Million | $829.64K | ▲ +395.5 pp |
| 2018 | -350.5% | $-622.52K | $177.61K | $800.13K | ▼ -429.5 pp |
| 2017 | 79.0% | $1.10 Million | $1.40 Million | $292.51K | ▼ -15.3 pp |
| 2016 | 94.4% | $2.33 Million | $2.47 Million | $139.24K | ▼ -2.7 pp |
| 2015 | 97.0% | $3.77 Million | $3.89 Million | $114.92K | ▲ +19.3 pp |
| 2014 | 77.7% | $5.26 Million | $6.77 Million | $1.51 Million | ▲ +44.7 pp |
| 2013 | 33.1% | $1.23 Million | $3.73 Million | $2.50 Million | ▼ -35.0 pp |
| 2012 | 68.0% | $2.05 Million | $3.02 Million | $965.94K | ▼ -23.3 pp |
| 2011 | 91.3% | $2.69 Million | $2.94 Million | $254.62K | ▲ +2.2 pp |
| 2010 | 89.1% | $2.40 Million | $2.69 Million | $293.31K | ▼ -3.9 pp |
| 2009 | 93.0% | $4.31 Million | $4.63 Million | $323.03K | ▲ +23.2 pp |
| 2008 | 69.8% | $894.78K | $1.28 Million | $387.29K | ▼ -6.3 pp |
| 2007 | 76.1% | $2.49 Million | $3.27 Million | $780.80K | — |